Should cancer patients receiving ICIs received COVID-19 vaccination?

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050498/
http://dx.doi.org/10.1007/s40278-021-94098-4
_version_ 1783679604381188096
collection PubMed
description
format Online
Article
Text
id pubmed-8050498
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80504982021-04-16 Should cancer patients receiving ICIs received COVID-19 vaccination? Reactions Weekly Clinical Study Springer International Publishing 2021-04-17 2021 /pmc/articles/PMC8050498/ http://dx.doi.org/10.1007/s40278-021-94098-4 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Should cancer patients receiving ICIs received COVID-19 vaccination?
title Should cancer patients receiving ICIs received COVID-19 vaccination?
title_full Should cancer patients receiving ICIs received COVID-19 vaccination?
title_fullStr Should cancer patients receiving ICIs received COVID-19 vaccination?
title_full_unstemmed Should cancer patients receiving ICIs received COVID-19 vaccination?
title_short Should cancer patients receiving ICIs received COVID-19 vaccination?
title_sort should cancer patients receiving icis received covid-19 vaccination?
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050498/
http://dx.doi.org/10.1007/s40278-021-94098-4

Ejemplares similares